Logo image of VRA

VERA BRADLEY INC (VRA) Stock Fundamental Analysis

NASDAQ:VRA - Nasdaq - US92335C1062 - Common Stock - Currency: USD

3.14  -0.08 (-2.48%)

After market: 3.06 -0.08 (-2.55%)

Fundamental Rating

3

VRA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 50 industry peers in the Textiles, Apparel & Luxury Goods industry. VRA has a great financial health rating, but its profitability evaluates not so good. VRA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

VRA had negative earnings in the past year.
VRA had a negative operating cash flow in the past year.
Of the past 5 years VRA 4 years were profitable.
VRA had a positive operating cash flow in 4 of the past 5 years.
VRA Yearly Net Income VS EBIT VS OCF VS FCFVRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

Looking at the Return On Assets, with a value of -4.76%, VRA is doing worse than 71.43% of the companies in the same industry.
The Return On Equity of VRA (-7.58%) is worse than 67.35% of its industry peers.
Industry RankSector Rank
ROA -4.76%
ROE -7.58%
ROIC N/A
ROA(3y)-3.09%
ROA(5y)-0.92%
ROE(3y)-5.1%
ROE(5y)-1.45%
ROIC(3y)N/A
ROIC(5y)N/A
VRA Yearly ROA, ROE, ROICVRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

VRA's Profit Margin has declined in the last couple of years.
In the last couple of years the Operating Margin of VRA has declined.
Looking at the Gross Margin, with a value of 52.19%, VRA is in line with its industry, outperforming 59.18% of the companies in the same industry.
VRA's Gross Margin has been stable in the last couple of years.
VRA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 52.19%
OM growth 3Y-16.78%
OM growth 5Y-9.23%
PM growth 3Y-3.59%
PM growth 5Y-19.74%
GM growth 3Y-1.33%
GM growth 5Y-1.02%
VRA Yearly Profit, Operating, Gross MarginsVRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

More info and screens

7

2. Health

2.1 Basic Checks

VRA does not have a ROIC to compare to the WACC, probably because it is not profitable.
VRA has about the same amout of shares outstanding than it did 1 year ago.
VRA has less shares outstanding than it did 5 years ago.
VRA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
VRA Yearly Shares OutstandingVRA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
VRA Yearly Total Debt VS Total AssetsVRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

VRA has an Altman-Z score of 2.85. This is not the best score and indicates that VRA is in the grey zone with still only limited risk for bankruptcy at the moment.
VRA has a Altman-Z score (2.85) which is comparable to the rest of the industry.
VRA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.85
ROIC/WACCN/A
WACC10.1%
VRA Yearly LT Debt VS Equity VS FCFVRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

VRA has a Current Ratio of 3.09. This indicates that VRA is financially healthy and has no problem in meeting its short term obligations.
VRA has a Current ratio of 3.09. This is amongst the best in the industry. VRA outperforms 81.63% of its industry peers.
A Quick Ratio of 0.89 indicates that VRA may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.89, VRA is doing worse than 71.43% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.09
Quick Ratio 0.89
VRA Yearly Current Assets VS Current LiabilitesVRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

2

3. Growth

3.1 Past

VRA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -140.68%.
VRA shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -1.76% yearly.
The Revenue for VRA has decreased by -16.39% in the past year. This is quite bad
VRA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.50% yearly.
EPS 1Y (TTM)-140.68%
EPS 3Y-4.5%
EPS 5Y-1.76%
EPS Q2Q%-242.11%
Revenue 1Y (TTM)-16.39%
Revenue growth 3Y0.18%
Revenue growth 5Y2.5%
Sales Q2Q%-29.92%

3.2 Future

Based on estimates for the next years, VRA will show a small growth in Earnings Per Share. The EPS will grow by 0.95% on average per year.
VRA is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -2.79% yearly.
EPS Next Y-152.37%
EPS Next 2Y-30.27%
EPS Next 3Y0.95%
EPS Next 5YN/A
Revenue Next Year-19.77%
Revenue Next 2Y-8.26%
Revenue Next 3Y-2.79%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
VRA Yearly Revenue VS EstimatesVRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
VRA Yearly EPS VS EstimatesVRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 1 1.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

VRA reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
VRA is valuated reasonably with a Price/Forward Earnings ratio of 11.96.
Based on the Price/Forward Earnings ratio, VRA is valued a bit cheaper than 77.55% of the companies in the same industry.
VRA is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 22.65, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 11.96
VRA Price Earnings VS Forward Price EarningsVRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

VRA's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. VRA is cheaper than 83.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.43
VRA Per share dataVRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-30.27%
EPS Next 3Y0.95%

More info and screens

0

5. Dividend

5.1 Amount

VRA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

VERA BRADLEY INC

NASDAQ:VRA (2/24/2025, 8:01:22 PM)

After market: 3.06 -0.08 (-2.55%)

3.14

-0.08 (-2.48%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)12-11 2024-12-11/bmo
Earnings (Next)03-12 2025-03-12/bmo
Inst Owners72.57%
Inst Owner Change-98.85%
Ins Owners8.31%
Ins Owner Change-0.72%
Market Cap87.07M
Analysts80
Price Target6.38 (103.18%)
Short Float %11.95%
Short Ratio7.96
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-283.77%
Min EPS beat(2)-545.54%
Max EPS beat(2)-21.99%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-14.12%
Min Revenue beat(2)-19.17%
Max Revenue beat(2)-9.07%
Revenue beat(4)0
Avg Revenue beat(4)-10.74%
Min Revenue beat(4)-19.17%
Max Revenue beat(4)-3.02%
Revenue beat(8)1
Avg Revenue beat(8)-6.74%
Revenue beat(12)2
Avg Revenue beat(12)-5.79%
Revenue beat(16)3
Avg Revenue beat(16)-4.7%
PT rev (1m)0%
PT rev (3m)-3.85%
EPS NQ rev (1m)-50%
EPS NQ rev (3m)-74%
EPS NY rev (1m)-166.67%
EPS NY rev (3m)-380%
Revenue NQ rev (1m)-9.98%
Revenue NQ rev (3m)-23.55%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-7.34%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 11.96
P/S 0.21
P/FCF N/A
P/OCF N/A
P/B 0.39
P/tB 0.4
EV/EBITDA 6.43
EPS(TTM)-0.24
EYN/A
EPS(NY)0.26
Fwd EY8.36%
FCF(TTM)-0.58
FCFYN/A
OCF(TTM)-0.32
OCFYN/A
SpS14.61
BVpS8.12
TBVpS7.9
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.76%
ROE -7.58%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 52.19%
FCFM N/A
ROA(3y)-3.09%
ROA(5y)-0.92%
ROE(3y)-5.1%
ROE(5y)-1.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-16.78%
OM growth 5Y-9.23%
PM growth 3Y-3.59%
PM growth 5Y-19.74%
GM growth 3Y-1.33%
GM growth 5Y-1.02%
F-Score5
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 28.97%
Cap/Sales 1.79%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.09
Quick Ratio 0.89
Altman-Z 2.85
F-Score5
WACC10.1%
ROIC/WACCN/A
Cap/Depr(3y)41.13%
Cap/Depr(5y)40.92%
Cap/Sales(3y)1.15%
Cap/Sales(5y)1.47%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-140.68%
EPS 3Y-4.5%
EPS 5Y-1.76%
EPS Q2Q%-242.11%
EPS Next Y-152.37%
EPS Next 2Y-30.27%
EPS Next 3Y0.95%
EPS Next 5YN/A
Revenue 1Y (TTM)-16.39%
Revenue growth 3Y0.18%
Revenue growth 5Y2.5%
Sales Q2Q%-29.92%
Revenue Next Year-19.77%
Revenue Next 2Y-8.26%
Revenue Next 3Y-2.79%
Revenue Next 5YN/A
EBIT growth 1Y-252.29%
EBIT growth 3Y-16.63%
EBIT growth 5Y-6.96%
EBIT Next Year-108.26%
EBIT Next 3Y9.21%
EBIT Next 5YN/A
FCF growth 1Y34.57%
FCF growth 3Y43.39%
FCF growth 5Y4.49%
OCF growth 1Y45.21%
OCF growth 3Y32.35%
OCF growth 5Y1.94%